James L. Wade III, MD, FACP, FASCO, discusses the importance of clinical trials in the community.
James L. Wade III, MD, FACP, FASCO, founder of Cancer Care Specialists of Illinois and former President of ACCC, discusses the importance of clinical trials in the community.
Wade says that in the 1980s, researchers believed they only needed the right drug to have a cure for cancer. In the 1990s, the focus was on finding the right dose. Theories like these, bone marrow transplant, and monoclonal antibodies have come and gone, Wade notes.
Phase 3 CheckMate -73L of Nivolumab/Ipilimumab in NSCLC Misses PFS End Point
May 13th 2024Nivolumab with ipilimumab did not lead to progression-free survival benefits in patients with unresectable stage III non-small cell lung cancer, missing the primary end point of the CheckMate -73L study.
Read More
FPI-2265 Dosing Commences in Phase 2 AlphaBreak Trial for mCRPC
May 10th 2024The first patient has been dosed in the phase 2 AlphaBreak trial with FPI-2265 for the treatment of metastatic castration-resistant prostate cancer, marking a significant milestone in advanced cancer treatment.
Read More